dutasterida + tansulosina betude 0.5 mg + 0.4 mg cápsula
pharmakern portugal - produtos farmacêuticos, sociedade unipessoal, lda. - dutasterida + tansulosina - cápsula - 0.5 mg + 0.4 mg - dutasterida 0.5 mg ; tansulosina, cloridrato 0.4 mg - tamsulosin and dutasteride - genérico - duração do tratamento: longa duração
amoxicilina + ácido clavulânico sandoz 600 mg/5 ml + 42.9 mg/5 ml pó para suspensão oral
sandoz farmacêutica, lda. - amoxicilina + Ácido clavulânico - pó para suspensão oral - 600 mg/5 ml + 42.9 mg/5 ml - amoxicilina tri-hidratada 137.74 mg/ml ; clavulanato de potássio 10.22 mg/ml - amoxicillin and beta-lactamase inhibitor - genérico - duração do tratamento: curta ou média duração
silodosina generis 4 mg cápsula
generis farmacêutica, s.a. - silodosina - cápsula - 4 mg - silodosina 4 mg - silodosin - genérico - duração do tratamento: longa duração
silodosina generis 8 mg cápsula
generis farmacêutica, s.a. - silodosina - cápsula - 8 mg - silodosina 8 mg - silodosin - genérico - duração do tratamento: longa duração
silodosina generis 4 mg cápsula
generis farmacêutica, s.a. - silodosina - cápsula - 4 mg - silodosina 4 mg - silodosin - genérico - duração do tratamento: longa duração
enhertu
daiichi sankyo europe gmbh - trastuzumab deruxtecan - neoplasias do peito - agentes antineoplásicos - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.
silodosina aurovitas 8 mg cápsula
generis farmacêutica, s.a. - silodosina - cápsula - 8 mg - silodosina 8 mg - silodosin - genérico - duração do tratamento: longa duração
silodosina aurovitas 4 mg cápsula
generis farmacêutica, s.a. - silodosina - cápsula - 4 mg - silodosina 4 mg - silodosin - genérico - duração do tratamento: longa duração
silodosina aurovitas 4 mg cápsula
generis farmacêutica, s.a. - silodosina - cápsula - 4 mg - silodosina 4 mg - silodosin - genérico - duração do tratamento: longa duração
garra do diabo gotas
herbarium laboratorio botanico ltda - fitoterapico simples